Comprehensive supply chain solutions for the Life Sciences
CryoPortal Login
  • English
    • Español (Spanish)
    • Français (French)
    • 日本語 (Japanese)
    • 简体中文 (Chinese)
Cryoport Systems logo
  • Industry Expertise
    • Cell Therapy
    • Gene Therapy
    • Biologics
    • Support by Development Phase
      • Pre-Clinical Programs
      • Phase I Clinical Programs
      • Phase II Clinical Programs
      • Phase III Clinical Programs
      • Commercial Programs
    • Reproductive Medicine
      • Intended Parents
      • Clinics
    • Animal Health
      • Animal Pharmaceuticals
      • Livestock Management
      • Veterinary Care
  • Trusted Solutions
    • Shipping Systems
      • Cryogenic (below -150°C) Shipping Systems
        • Cryoport Express® Cryogenic Standard Shipping System
        • Cryoport Express® Cryogenic Combo Shipping System
        • Cryoport Express® Cryogenic HV3 Shipping System
        • Cryomax® Cryogenic Shipping System
      • Ultra Cold (-60 to -80°C) Shipping Systems
        • Cryoport Elite® Ultra Cold
      • Refrigerated (2 to 8°C) and CRT (15 to 25°C) Shipping Systems
        • Cryoport Express® C3™ Shipping System
      • Cryoport Accessories
        • Cryoport Safepak® System
    • Transportation
      • Cryoshuttle®
    • BioServices
      • Biostorage Solutions
      • Kit Production
      • Secondary Packaging and Labelling
      • Clinical Sample Management
      • Regulatory & QP Services
    • Consulting Services
      • Shipping Risk Assessment and Shipping Lane Qualification
      • Shipping System and Packaging Performance Qualification
      • Custom Packaging and Accessory Development
    • IntegriCell® Cryopreservation
  • Technology
    • Cryoportal®
    • Veri-Clean®
    • Chain of Compliance®
    • Tec4med
    • Custom Packaging and Accessory Development
  • About Us
    • Our People
    • Management
    • Quality
    • Careers
    • Cryoport’s Family of Companies
  • Resources
    • Events
    • Supply Chain Blog
    • Company News & Articles
    • Brochures and Spec Sheets
    • Instructions
    • Order Forms
    • White Papers and Case Studies
    • Videos/Webinars
    • Reference Materials
      • Cryoportal® 2 Training Materials
      • Validation Package Request
      • Data Station Direction & Validation
      • Quality Change Notification Request
      • Certifications
      • Smartpak II™ Airline Authorizations
  • Contact Us
    • Request a Quote
    • Locations
  • Investor Relations
CryoPortal Login
Request Info
Request a Quote
Request a Quote
Request Info Request a Quote

Articles Archives

Building the Infrastructure to Enable Patient Access to Advanced Therapies: A Deep-Dive with Dominic Clarke, VP of Technical Operations
Articles
09/02/2026

Building the Infrastructure to Enable Patient Access to Advanced Therapies: A Deep-Dive with Dominic Clarke, VP of Technical Operations

Following Pharmaceutical Commerce’s podcast with Adam Fox, Chief Quality & Regulatory Affairs Officer at Cryoport Systems, we wanted to explore several topics that deserve a deeper look. As cell and gene therapies continue to advance, quality leaders are discovering that supply chains have become an extension of the quality system itself.

Read More

Read More
Global Expansion Starts with Global Consistency
Animal Pharmaceuticals
08/03/2026

Global Expansion Starts with Global Consistency

Expanding a global presence has become a strategic necessity for animal health organizations. New markets, manufacturing sites, distribution partners, and veterinary networks create opportunities to expand programs across regions.  The challenge is not reaching those regions. The challenge is maintaining the same quality standards, operational controls, visibility, and compliance readiness everywhere a program operates.

Read More

Read More
Continuous Data Isn’t Optional for Animal Health
Animal Pharmaceuticals
06/22/2026

Continuous Data Isn’t Optional for Animal Health

Animal health teams are moving more temperature-sensitive materials through more complex distribution networks than ever before. Vaccines, biotherapeutics, reproductive materials, diagnostics, and advanced therapies are all crossing longer distances and passing through more handoffs to reach a wider mix of farms, clinics, production facilities, and research sites. As that complexity grows, the standard for what logistics data must show is also changing. Programs are increasingly expected to document the actual condition and custody of materials throughout transit rather than rely on fragmented records assembled after delivery.

Read More

Read More
Quality Assurance in Animal Health Supply Chains: How to Mitigate Risks
Animal Pharmaceuticals
10/21/2025

Quality Assurance in Animal Health Supply Chains: How to Mitigate Risks

In the animal health industry, innovation doesn’t end when a new therapy leaves the lab. From the moment a product is ready to move, its quality depends on one thing above all else: a controlled, reliable supply chain. In this context, quality assurance (QA) goes beyond a regulatory requirement and quickly becomes a critical safeguard that ensures every shipment maintains its efficacy and compliance throughout the complexities of transport.

Read More

Read More
The Connected Chain: Why Supply Chain Integration Matters in Advanced Therapy Manufacturing
Managing the Cold Chain
10/15/2025

The Connected Chain: Why Supply Chain Integration Matters in Advanced Therapy Manufacturing

Contract Development and Manufacturing Organizations (CDMOs) are at the heart of the advanced therapy ecosystem, managing complex, high-stakes programs that demand speed and compliance. As therapies move from early development into clinical trials and through to commercialization, every stage of manufacturing, packaging, biostorage, and final drug delivery need to align perfectly for seamless execution. Yet in many cases, these functions are managed by multiple vendors, each operating in isolation. The result is a fragmented supply chain that increases risk while slowing execution due to layers of operational burden.  

Read More

Read More
Revolutionizing Animal Health Logistics: How Advanced Technology Protects Product Quality
Animal Pharmaceuticals
09/23/2025

Revolutionizing Animal Health Logistics: How Advanced Technology Protects Product Quality

Innovation in the animal health sector extends far beyond the laboratory. While researchers develop next-generation vaccines, advanced biologics, and complex veterinary therapeutics, the logistics that bring these products from manufacturing to the field are evolving just as rapidly. For companies delivering temperature-sensitive products across continents, ensuring quality has quickly become mission-critical. A shipment that arrives late, compromised, or out of specification can affect patient outcomes and regulatory compliance, all while quietly eroding operational efficiency and profit margins.

Read More

Read More
Built for Speed: How Cryoport Systems Delivers Without Compromise
Managing the Cold Chain
08/01/2025

Built for Speed: How Cryoport Systems Delivers Without Compromise

In the life sciences, time isn’t just money, it impacts patient outcomes, regulatory compliance, and even trial integrity. When a temperature-sensitive shipment is delayed due to inventory shipper shortages or logistical bottlenecks, the impact can cascade across an entire program. Unfortunately, these scenarios aren’t theoretical. When you’re working with irreplaceable biologic materials, this kind of disruption quickly moves from inconvenient to unacceptable.  

Read More

Read More
Ensuring Safe, On-Time Deliveries for Animal Biopharma
Animal Pharmaceuticals
06/17/2025

Ensuring Safe, On-Time Deliveries for Animal Biopharma

Transporting advanced therapeutics for the animal health industry is just as time- and temperature-sensitive as human therapeutics, yet it is not often managed with the same level of care. This results in biologics and vaccines running into preventable risk during transit. Whether you’re supporting a clinical trial, delivering commercial supply, or responding to a health emergency, ensuring the quality, compliance, and visibility of every shipment is crucial.

Read More

Read More
Delivering Over 5 Billion Doses of Biotherapeutics to Protect Animal Health Worldwide
Animal Pharmaceuticals
04/16/2025

Delivering Over 5 Billion Doses of Biotherapeutics to Protect Animal Health Worldwide

 In 2024, Cryoport Systems achieved a remarkable milestone: the delivery of over 5 billion doses of biotherapeutics, including cell-based therapies, antibody-based therapies, and vaccines to the global animal health industry. This achievement is the result of our unwavering commitment to ensuring the health and well-being of animals across the world, from livestock that sustain global food supply chains to the beloved companion animals that enrich our lives. 

Read More

Read More
Load More

Categories

  • All (63)

Tags

  • Asia
  • ATMPs
  • Biologics
  • Biosecurity
  • BioServices
  • Biostorage
  • Cell Therapy
  • Cold Chain Management
  • Commercialization
  • Cryopreservation
  • Europe
  • Gene Therapy
  • Global Logistics Tracking
  • Global Supply Chain Management
  • International Shipping
  • Risk Mitigation
  • Supply Chain Management

Subscribe to our newsletter

Never miss another update! Join our mailing list for all the latest news, events, and announcements.

  • Clinical Trial icon Trusted with 779 clinical trials
  • Approved therapies icons Supporting 22 approved therapies
  • Quality icon Robust quality standards
  • Client service icon 24/7/365 support team
  • About Us
  • Industries
  • Solutions
  • Resources
  • Technology & Innovation
  • Contact Us
  • About Us
  • Industries
  • Solutions
  • Resources
  • Technology & Innovation
  • Contact Us
Cryoport Systems logo
  • Privacy Policy
  • Terms of Use
  • Careers
Request a Quote
  • youtube
  • twitter
  • linkedin
Cryoport Systems logo

© 2026 Cryoport Systems, LLC. All rights reserved.
Cryoport® is a trademark of Cryoport, Inc. and used with permission by Cryoport Systems, LLC

  • youtube
  • twitter
  • linkedin